NO20021094L - Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer - Google Patents

Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer

Info

Publication number
NO20021094L
NO20021094L NO20021094A NO20021094A NO20021094L NO 20021094 L NO20021094 L NO 20021094L NO 20021094 A NO20021094 A NO 20021094A NO 20021094 A NO20021094 A NO 20021094A NO 20021094 L NO20021094 L NO 20021094L
Authority
NO
Norway
Prior art keywords
prophylactic
therapeutic drugs
ophthalmic diseases
ophthalmic
diseases
Prior art date
Application number
NO20021094A
Other languages
English (en)
Other versions
NO20021094D0 (no
Inventor
Hiroaki Naka
Kazuhito Kawabata
Hideki Tokushige
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO20021094D0 publication Critical patent/NO20021094D0/no
Publication of NO20021094L publication Critical patent/NO20021094L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20021094A 1999-09-06 2002-03-05 Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer NO20021094L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25153899 1999-09-06
PCT/JP2000/006014 WO2001017527A1 (en) 1999-09-06 2000-09-05 Preventive and therapeutic agents for eye diseases

Publications (2)

Publication Number Publication Date
NO20021094D0 NO20021094D0 (no) 2002-03-05
NO20021094L true NO20021094L (no) 2002-05-06

Family

ID=17224318

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021094A NO20021094L (no) 1999-09-06 2002-03-05 Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer

Country Status (14)

Country Link
US (1) US6624193B1 (no)
EP (1) EP1213018A4 (no)
JP (1) JP4682495B2 (no)
KR (1) KR20020042667A (no)
CN (1) CN1387436A (no)
AU (1) AU6870800A (no)
BR (1) BR0013793A (no)
CA (1) CA2383971A1 (no)
HU (1) HUP0202745A2 (no)
MX (1) MXPA02002452A (no)
NO (1) NO20021094L (no)
NZ (1) NZ517556A (no)
WO (1) WO2001017527A1 (no)
ZA (1) ZA200201819B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552082B2 (en) * 2000-06-29 2003-04-22 Ono Pharmaceutical Co., Ltd. Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
JP5000835B2 (ja) * 2000-08-25 2012-08-15 千寿製薬株式会社 水性懸濁液剤
US7315848B2 (en) * 2001-12-12 2008-01-01 Aaron Pearse Web snippets capture, storage and retrieval system and method
WO2004064828A1 (ja) 2003-01-21 2004-08-05 Senju Pharmaceutical Co., Ltd. ２−アミノ−３−(４−ブロモベンゾイル)フェニル酢酸含有水性液剤
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
CA2597525A1 (en) * 2005-02-17 2006-08-24 Senju Pharmaceutical Co., Ltd. Solid ophthalmic drug for external use
WO2008042454A1 (en) 2006-09-29 2008-04-10 Johnson & Johnson Vision Care, Inc. Methods and ophthalmic devices used in the treatment of ocular allergies
CA2685230C (en) * 2007-05-04 2012-10-16 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
WO2008137826A2 (en) * 2007-05-07 2008-11-13 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
CN105362221A (zh) * 2009-03-03 2016-03-02 爱尔康研究有限公司 向眼部递送受体酪氨酸激酶抑制性(RTKi)化合物的药物组合物
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
KR102433489B1 (ko) * 2013-03-14 2022-08-17 팬옵티카, 인크. 눈의 후안부로의 약물 전달을 위한 안구용 제제
JP6960399B2 (ja) * 2015-06-16 2021-11-05 ウー・ロン−ツンWU, Rong−Tsun ドライアイを治療または防止する方法
EP3644966A4 (en) * 2017-06-29 2021-03-24 Advaite LLC TREATMENT AND DIAGNOSIS OF EYE SURFACE DISORDERS
US12102622B2 (en) * 2021-02-10 2024-10-01 Iolyx Therapeutics, Inc. Methods for ophthalmic delivery of roflumilast

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320253A (ja) * 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
CA1340191C (en) 1988-06-13 1998-12-15 Katsuhiro Imaki Derivatives of p-substituted phenyl ester of pivalic acid
EP0367514A3 (en) * 1988-10-27 1991-05-22 University Of Kentucky Research Foundation Human leukocyte elastase inhibitors and methods for producing and using same
ATE161016T1 (de) 1991-06-18 1997-12-15 Fujisawa Pharmaceutical Co Ws7622a enthaltende prophylaktische/therapeutische zusammensetzung zur vorbeugung und behandlung von verstreuter, intravaskulärer koagulation, chronischer, infektiöser atemwegskrankheiten oder chronischer bronchitis
GB9115811D0 (en) 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof
EP0539223A1 (en) 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
JPH05194366A (ja) * 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法

Also Published As

Publication number Publication date
US6624193B1 (en) 2003-09-23
KR20020042667A (ko) 2002-06-05
EP1213018A4 (en) 2004-04-14
WO2001017527A9 (fr) 2001-06-21
ZA200201819B (en) 2003-05-28
CN1387436A (zh) 2002-12-25
WO2001017527A1 (en) 2001-03-15
NZ517556A (en) 2003-08-29
MXPA02002452A (es) 2004-09-10
HUP0202745A2 (hu) 2003-01-28
CA2383971A1 (en) 2001-03-15
NO20021094D0 (no) 2002-03-05
AU6870800A (en) 2001-04-10
JP4682495B2 (ja) 2011-05-11
EP1213018A1 (en) 2002-06-12
BR0013793A (pt) 2002-05-14

Similar Documents

Publication Publication Date Title
NO20021094D0 (no) Profylaktiske og terapeutiske medikamenter for oftalmologiske sykdommer
DK1221919T3 (da) Oftalmisk lægemiddeladministrationsanordning
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
NO20021400D0 (no) Terapeutiske konazolinderivater
DK1637127T3 (da) Terapeutisk mikroskum
NO20015888L (no) Implanterbart gelpreparat og fremgangsmåter for fremstilling derav
NO20002831D0 (no) Medikament i myk tablettform og fremgangsmÕter for fremstilling av dette
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO20010556D0 (no) Fremgangsmåte for oftalmisk administrering
NO994014L (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
AU2002357830A1 (en) Methods and devices for therapeutic treatment cardiac and other pathologies
NO20014617L (no) 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20031656L (no) Kombinasjon omfattende camptothecin og et stillbenderivat for behandling avcancer
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
DK1372665T3 (da) Hormonerstatningsbehandling og administration
NO20026148D0 (no) Medisiner for forhindring og behandling av neurodegenerative sykdommer
EP1457210A4 (en) MEDICINE FOR THE TREATMENT AND / OR PREVENTION OF CONFORMATIONAL DISEASES
GB0225502D0 (en) Therapeutic and prophylactic preparations

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application